144 related articles for article (PubMed ID: 26636928)
21. Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury.
Samuels R; Bayerri CR; Sayer JA; Price DA; Payne BAI
AIDS; 2017 Jun; 31(9):1297-1301. PubMed ID: 28323756
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients.
Cusato J; Calcagno A; Marinaro L; Avataneo V; DʹAvolio A; Di Perri G; Bonora S
Pharmacogenomics J; 2020 Apr; 20(2):202-212. PubMed ID: 31619748
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients.
Punyawudho B; Thammajaruk N; Thongpeang P; Matthews G; Lewin SR; Burger D; Ruxrungtham K; Avihingsanon A
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):947-54. PubMed ID: 26308175
[TBL] [Abstract][Full Text] [Related]
24. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
[TBL] [Abstract][Full Text] [Related]
25. Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
Wanga V; Venuto C; Morse GD; Acosta EP; Daar ES; Haas DW; Li C; Shepherd BE
Pharmacogenet Genomics; 2015 Sep; 25(9):450-61. PubMed ID: 26148204
[TBL] [Abstract][Full Text] [Related]
26. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Tantanathip P; Chimsuntorn S; Nilkamhang S; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):643-50. PubMed ID: 21706942
[TBL] [Abstract][Full Text] [Related]
27. Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.
Zeder AJ; Hilge R; Schrader S; Bogner JR; Seybold U
Infection; 2016 Oct; 44(5):641-9. PubMed ID: 27256076
[TBL] [Abstract][Full Text] [Related]
28. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
[TBL] [Abstract][Full Text] [Related]
29. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
Taneva E; Crooker K; Park SH; Su JT; Ott A; Cheshenko N; Szleifer I; Kiser PF; Frank B; Mesquita PM; Herold BC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1667-75. PubMed ID: 26711762
[TBL] [Abstract][Full Text] [Related]
30. Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology.
Schmid H; Tokarska-Schlattner M; Füeßl B; Röder M; Kay L; Attia S; Lederer SR; Goebel FD; Schlattner U; Bogner JR
Antivir Ther; 2013; 18(2):193-204. PubMed ID: 22894916
[TBL] [Abstract][Full Text] [Related]
31. Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana.
Nartey ET; Tetteh RA; Yankey BA; Mantel-Teeuwisse AK; Leufkens HGM; Dodoo ANO; Lartey M
BMC Res Notes; 2019 Jul; 12(1):445. PubMed ID: 31331365
[TBL] [Abstract][Full Text] [Related]
32. Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
Calcagno A; Fiumanò M; Zugna D; Cusato J; Montrucchio C; Marinaro L; Trentini L; Ferrara M; D'Avolio A; Pizzi C; Di Perri G; Bonora S
Pharmacogenomics J; 2019 Feb; 19(1):65-71. PubMed ID: 30405212
[TBL] [Abstract][Full Text] [Related]
33. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.
Vrouenraets SM; Fux CA; Wit FW; Garcia EF; Furrer H; Brinkman K; Hoek FJ; Abeling NG; Krediet RT; Reiss P;
AIDS; 2011 Nov; 25(17):2149-55. PubMed ID: 21857491
[TBL] [Abstract][Full Text] [Related]
34. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
Kinai E; Hanabusa H
AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
[TBL] [Abstract][Full Text] [Related]
35. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
36. Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued.
Nishijima T; Mutoh Y; Kawasaki Y; Tomonari K; Kikuchi Y; Gatanaga H; Oka S;
AIDS; 2018 Jan; 32(2):179-188. PubMed ID: 29028660
[TBL] [Abstract][Full Text] [Related]
37. Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.
Young B; Buchacz K; Moorman A; Wood KC; Brooks JT;
AIDS Patient Care STDS; 2009 Aug; 23(8):589-92. PubMed ID: 19591609
[TBL] [Abstract][Full Text] [Related]
38. Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients.
Rungtivasuwan K; Avihingsanon A; Thammajaruk N; Mitruk S; Burger DM; Ruxrungtham K; Punyawudho B; Pengsuparp T
Antimicrob Agents Chemother; 2015; 59(6):3240-5. PubMed ID: 25801567
[TBL] [Abstract][Full Text] [Related]
39. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
Nishijima T; Kawasaki Y; Tanaka N; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
AIDS; 2014 Aug; 28(13):1903-10. PubMed ID: 25259702
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
Bonjoch A; Juega J; Puig J; Pérez-Alvarez N; Aiestarán A; Echeverría P; Pérez V; Clotet B; Romero R; Bonet J; Negredo E
AIDS Patient Care STDS; 2014 Oct; 28(10):524-9. PubMed ID: 25238104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
